IXICO plc (AIM:IXI)

Market Cap	17.99M +68.8%
Revenue (ttm)	7.28M +13.0%
Net Income	-1.82M
EPS	-0.02
Shares Out	218.05M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,090
Open	8.50
Previous Close	8.25
Day's Range	8.00 - 8.50
52-Week Range	6.26 - 15.00
Beta	0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 18, 2026

About IXICO

IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services. It also provides imaging contract research organization solutions, including imaging biomarkers, such as radiological reads, volumetric MRI, PET and SPECT, and advanced MRI...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 79
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: IXI

Financial Performance

In fiscal year 2025, IXICO's revenue was 6.53 million, an increase of 13.32% compared to the previous year's 5.77 million. Losses were -1.65 million, -17.49% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 6, 2026

Data Sources Report a data error